Environmental impact and costs of a switching program of intravenous to subcutaneous infliximab in Inflammatory Bowel Disease

Publication

dc.contributor.author	Oliveira, R.
dc.contributor.author	Roseira, J.
dc.contributor.author	Araújo, N.
dc.contributor.author	Cavaco, C.
dc.contributor.author	André, J.
dc.contributor.author	Sousa, M.
dc.contributor.author	Sousa, H. Tavares de
dc.contributor.author	Cunha, M.
dc.date.accessioned	2025-03-06T11:25:52Z
dc.date.available	2025-03-06T11:25:52Z
dc.date.issued	2025-01
dc.description.abstract	We aimed to compare real-life direct and indirect costs and the environmental impact of switching IBD patients from IV to SC infliximab (IFX).	eng
dc.identifier.doi	10.1093/ecco-jcc/jjae190.1058
dc.identifier.issn	1873-9946
dc.identifier.issn	1876-4479
dc.identifier.uri	http://hdl.handle.net/10400.1/26862
dc.language.iso	eng
dc.peerreviewed	yes
dc.publisher	Oxford University Press
dc.relation.hasversion	https://academic.oup.com/ecco-jcc/article/19/Supplement_1/i1678/7967822#google_vignette
dc.relation.ispartof	Journal of Crohn's and Colitis
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.title	Environmental impact and costs of a switching program of intravenous to subcutaneous infliximab in Inflammatory Bowel Disease	eng
dc.type	conference object
dspace.entity.type	Publication
oaire.citation.endPage	i1681
oaire.citation.issue	Suplemento 1
oaire.citation.startPage	i1681
oaire.citation.title	Journal of Crohns & Colitis
oaire.citation.volume	19
oaire.version	http://purl.org/coar/version/c_970fb48d4fbd8a85

Files

Now showing 1 - 1 of 1

Name:: Environmental impact and costs of a switching program of intravenous to subcutaneous infliximab in Inflammatory Bowel Disease.pdf
Size:: 476.23 KB
Format:: Adobe Portable Document Format

Now showing 1 - 1 of 1